Skip to main content

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) Investor Securities Class Action Lawsuit 06/08/2021

  • If you purchased shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

September 5, 2023 - A third amended complaint was filed. July 7, 2023 - The court issued an order granting motion to dismiss. Leave was given to amend all claims except claim 2. January 30, 2023 - A motion was filed to dismiss the second amended complaint. November 28, 2021 - A second amended complaint was filed. September 28, 2022 - The court issued an order granting motion to dismis...

You must register (for free) or login to view the entire case.